David Koos, Bio-Matrix Scientific Group, Inc. (THII: OTCBB)
Click the Arrow Below to Listen to this Episode
Yahoo! Finance and Agoracom features small cap newsmakers and innovators. In Episode 3 of the Yahoo! Finance Small Cap podcast, Pat Beechinor interviews David Koos, CEO of Bio-Matrix Scientific Group, Inc. (THII: OTCBB).
Show Notes
00:13 - Pat Beechinor introduces Bio-Matrix Scientific Group, Inc. and David Koos.
01:10 - David speaks about the the sale of Tasco Holdings International and how that fits into Bio-Matrix Scientific Group, Inc.’s overall strategy. David also mentions why diversifying their offerings is a better strategy for growth.
02:24 - David talks about the latest developments in next generation cryogenics, stem cell research and regenerative medicine.
04:15 - Bio-Matrix Scientific Group, Inc. is completing a new facility in San Diego. David talks about the timeline for completion and when the stem cell banking facilities and stem cell processing labs will be ready.
05:39 - David explains why Bio-Matrix Scientific Group, Inc. stands head and shoulders above its competitors, in particular, due to its focus on banking stem cells for commercial use. David also spoke about the 30th Annual General Meeting of the American Association of Tissue Banks and why attending this event is important to Bio-Matrix Scientific Group, Inc.
07:12 - David explains where he wants to position Bio-Matrix Scientific Group, Inc. in the next few months.
07:53 - David explains how people can find out more about Bio-Matrix Scientific Group, Inc. Pat thanks David for his time.
Show Resources